| pubmed-article:10698453 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:10698453 | lifeskim:mentions | umls-concept:C0205111 | lld:lifeskim |
| pubmed-article:10698453 | lifeskim:mentions | umls-concept:C0037473 | lld:lifeskim |
| pubmed-article:10698453 | lifeskim:mentions | umls-concept:C0456387 | lld:lifeskim |
| pubmed-article:10698453 | lifeskim:mentions | umls-concept:C0243077 | lld:lifeskim |
| pubmed-article:10698453 | lifeskim:mentions | umls-concept:C0679622 | lld:lifeskim |
| pubmed-article:10698453 | lifeskim:mentions | umls-concept:C0205314 | lld:lifeskim |
| pubmed-article:10698453 | lifeskim:mentions | umls-concept:C0618375 | lld:lifeskim |
| pubmed-article:10698453 | pubmed:issue | 3 | lld:pubmed |
| pubmed-article:10698453 | pubmed:dateCreated | 2000-3-28 | lld:pubmed |
| pubmed-article:10698453 | pubmed:abstractText | A series of 2,3-disubstituted-4-phenylquinolines were prepared and were found to inhibit the apical sodium co-dependent bile acid transporter (ASBT). Alkyl and ester substitution at the 3-position showed comparable activities while substitution at the 2-position was much more sensitive to the nature of the substituent. The synthesis and in vitro potency data are presented for this novel class of compounds. | lld:pubmed |
| pubmed-article:10698453 | pubmed:language | eng | lld:pubmed |
| pubmed-article:10698453 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:10698453 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:10698453 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:10698453 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:10698453 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:10698453 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:10698453 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:10698453 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:10698453 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:10698453 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:10698453 | pubmed:month | Feb | lld:pubmed |
| pubmed-article:10698453 | pubmed:issn | 0960-894X | lld:pubmed |
| pubmed-article:10698453 | pubmed:author | pubmed-author:ChenF PFP | lld:pubmed |
| pubmed-article:10698453 | pubmed:author | pubmed-author:ReinhardE JEJ | lld:pubmed |
| pubmed-article:10698453 | pubmed:author | pubmed-author:HuangH CHC | lld:pubmed |
| pubmed-article:10698453 | pubmed:author | pubmed-author:KellerB TBT | lld:pubmed |
| pubmed-article:10698453 | pubmed:author | pubmed-author:ReitzD BDB | lld:pubmed |
| pubmed-article:10698453 | pubmed:author | pubmed-author:BeaudryJJ | lld:pubmed |
| pubmed-article:10698453 | pubmed:author | pubmed-author:TollefsonM... | lld:pubmed |
| pubmed-article:10698453 | pubmed:author | pubmed-author:VernierW FWF | lld:pubmed |
| pubmed-article:10698453 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:10698453 | pubmed:day | 7 | lld:pubmed |
| pubmed-article:10698453 | pubmed:volume | 10 | lld:pubmed |
| pubmed-article:10698453 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:10698453 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:10698453 | pubmed:pagination | 277-9 | lld:pubmed |
| pubmed-article:10698453 | pubmed:dateRevised | 2004-12-3 | lld:pubmed |
| pubmed-article:10698453 | pubmed:meshHeading | pubmed-meshheading:10698453... | lld:pubmed |
| pubmed-article:10698453 | pubmed:meshHeading | pubmed-meshheading:10698453... | lld:pubmed |
| pubmed-article:10698453 | pubmed:meshHeading | pubmed-meshheading:10698453... | lld:pubmed |
| pubmed-article:10698453 | pubmed:meshHeading | pubmed-meshheading:10698453... | lld:pubmed |
| pubmed-article:10698453 | pubmed:meshHeading | pubmed-meshheading:10698453... | lld:pubmed |
| pubmed-article:10698453 | pubmed:meshHeading | pubmed-meshheading:10698453... | lld:pubmed |
| pubmed-article:10698453 | pubmed:year | 2000 | lld:pubmed |
| pubmed-article:10698453 | pubmed:articleTitle | A novel class of apical sodium co-dependent bile acid transporter inhibitors: the 2,3-disubstituted-4-phenylquinolines. | lld:pubmed |
| pubmed-article:10698453 | pubmed:affiliation | Searle Discovery, Monsanto Life Sciences, St. Louis, MO 63198, USA. | lld:pubmed |
| pubmed-article:10698453 | pubmed:publicationType | Journal Article | lld:pubmed |
| http://linkedlifedata.com/r... | http://linkedlifedata.com/r... | pubmed-article:10698453 | lld:chembl |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:10698453 | lld:pubmed |
